Advancing Collaboration, Discovery and Translation
From its launch in 2007 to the present, the Johns Hopkins Medicine Brain Science Institute has upheld its mission, charting progress with novel discoveries, therapies and collaborations to support brain health and healing.
2007 (Milestone):
Launch of Brain Science Institute (BSi)
Technology Development and Commercialization Symposium
Pharma Alliances: Biogen, Eisai, Helsinn, Johnson and Johnson
2008 (Image):
First BSi Working Groups and Funding
Awarded $21 million in grants between 2008-2014
Learning, Arts and the Brain Summit
Launch of Brain Night Lecture Series
2009 (Milestone):
Creation of Center for Brain Imaging Science
Launch of Imaging Grant Program
Launch of BSi Cores
First Drug Discovery Bootcamp
2010 (Research):
Launch of Drug Discovery Initiative at Hopkins
100 scientists/clinicians for novel drugs
20 patents
150 publications
$200 million federal grants
Science of the Arts Symposium
Beauty and the Brain Partnership with the Walters Museum
Packard Global Annual Meeting
2011 (Research):
Launch of Neurodegeneration Program
$645 million in philanthropy
2 patents
100 publications
Developed faculty base
Discovery of major gene for ALS and Dementia
Science of the Arts Grants Funding
Awarded initial grant for creativity research led by Charles
Limb, MD
Funded five seminal arts research proposals
2012 (Research):
Creation of Neurocognition Program
Neurocognition Faculty Hire: Daniel O’Connor, MA, PhD, Assistant
Professor of Neuroscience
14 publications
$4.2 million extramural funding
SIN Grant Funding for Innovative Bridge Research Funding
First Graduate Drug Discovery Course
2013 (Milestone):
Launch of BSi Brain Talk Radio
Show and Podcasts
Launch ofFirst New Gene Therapy for Dementia and ALS
2014 (Research):
Neurocognition Faculty Hire: Gul Dolen, MD, PhD, Assistant Professor
of Neuroscience
12 publications
$4.1 million extramural funding
Patent pending
Clinical trials
Neurocognition Faculty Hire: Jeremiah Cohen, PhD, Assistant
Professor of Neuroscience
10 publications
$3.1 million in extramural funding
High Throughput Drug Screening Collaboration – Eisai
2015 (Milestone):
Launch of Answer ALS - Personalized Medicine for ALS
$42 million nationwide program
2016 (Milestone):
Launch of the International Arts + Mind Lab (IAM Lab)
Neurodegeneration Faculty Hire: Shuying Sun, PhD, Assistant
Professor of Pathology
Partnership with Team Gleason, Travelers Insurance
2017 (Research):
Academic Drug Discovery Consortium Symposium
Development of National Drug Translational Training Program with NIH
IAM Lab Development of Impact Thinking Model
New Johns Hopkins Drug Discovery Drug Company
Dracen Pharma - $41 million external investment
2018 (Milestone):
First Clinical Trial for Gene Therapy for ALS Dementia
Neurodegeneration Big Data Initiative
IBM Watson and Microsoft partnership
Caterpillar and American Airline partnerships
$150 million in grants
2 patents
100+ publications
New Johns Hopkins Drug Discovery Drug Companies
Lorem Pharma - $1 million investment
Adarga - $1 million investment
2019 (Research):
Neurodegeneration Expansion to Alzheimer’s Disease
Launched Answer AD - personalized stem cell tools for
Alzheimer's
New faculty hires: Lindsey Hayes MD, PhD, Assistant Professor of
Neurology; Matthew Elrick MD, PhD, Assistant Professor of
Neurology
Launch of IAM Lab Dialog Series
IAM Lab Launch of NeuroArts Blueprint with the Aspen Institute
2020 (Milestone):
IAM Lab Launch of COVID-19 NeuroArts Field Guide
IAM Lab Launch of the Arts for Health Equity and Social Justice
Series
Neurodegeneration Faculty Hire: Sarah Berth MD, PhD, Assistant
Professor of Neurology
Johns Hopkins Drug Discovery Hire: Jack Wei, PhD, Director,
Biochemistry and Assay Development
Johns Hopkins Drug Discovery Celebrates First Decade
160+ publications
9 different drug discovery programs
19 pharmaceutical partnerships
15 disease foundation partnerships
Government funding from 14 different US agencies
2020 (Milestone):
Naming of BSi to the Johns Hopkins Pedersen Brain Science Institute.